Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Autor: | Patel, Jai N *, Lopes, Karine Eboli *, Druhan, Lawrence J, Zeng, Hang *, Beam, Travis *, Moore, Donald C *, Salem, Ahmed *, Hamadeh, Issam *, Savage, Quanisha *, Chojecki, Aleksander L., Ai, Jing, Knight, Thomas G., Ragon, Brittany Knick, Shah, Nilay A. *, Sanikommu, Srinivasa Reddy, Steuerwald, Nury M, Smith, Mathew *, Hamilton, Alicia *, Rangavajhula, Keerthana *, Bell, Ariel *, Drummond, Kendra *, Symanowski, James T. *, Grunwald, Michael R. |
---|---|
Zdroj: | In Blood 15 November 2022 140 Supplement 1:11530-11531 |
Databáze: | ScienceDirect |
Externí odkaz: |